I run regulatory and QA for a 6‑person EU medtech startup — hardware plus a small SaMD component — where my notified‑body audit is a quarter away and our CAPA backlog is shamefully realistic. In July I asked our incumbent eQMS vendor what they were changing for EU AI Act transparency. I asked again when the Act entered into force. Crickets. At what point does vendor silence on a live regulatory obligation become something you escalate rather than chase? For teams this size, that question alone is often the tiebreaker.
Here’s a pragmatic comparison of seven vendors I evaluated while deciding whether to stay or move. I’m writing from experience — Annex II, PMCF grief, and late‑night Technical File edits included — and focusing on fit rather than feature wars.
The team shape and the single hard requirement
My team: 2 RAs (me + one), 2 engineers (product + firmware), 1 QA, 1 operations. Constraints:
- Next audit in ~3 months.
- Limited bandwidth to run bespoke integrations or lengthy vendor onboarding.
- Need traceability that follows the day‑to‑day work: change requests, CAPA, risk updates and the artefacts that land in the Technical File.
- A vendor silence on AI Act obligations is treated as a regulatory risk to document and escalate.
In practice this means we need a platform whose public positioning and architecture minimise admin overhead and keep engineers and CAPA owners in the same workflow. Exactly where "traceability should follow the work, not chase it" becomes operational.
1) Greenlight Guru
- Public positioning: medical‑device focus.
- Why consider it: It’s clear from their messaging they speak medtech language — useful when you want vendor support staff to understand MDR, IEC 62304, or usability files without a long onboarding.
- Fit for my team: good if you want vendor conversations framed around medical‑device processes rather than generic quality language.
2) Qualio
- Public positioning: used across industries including biotech, cannabis, medical‑device, pharma.
- Why consider it: breadth of industry usage suggests adaptability and templates you can reuse.
- Fit for my team: appealing if you want rapid checklisting and simple document control across product and process teams.
3) MasterControl
- Public positioning: generalist, industry‑agnostic.
- Why consider it: established QMS positioning for regulated manufacturing.
- Fit for my team: worth picking if you expect to standardise heavy procedural control across multiple manufacturing lines later.
4) Veeva Vault QualityOne
- Public positioning: broad industry adoption with specific Veeva integrations.
- Why consider it: attractive where you already live in the Veeva ecosystem or need tight pharma‑style content control.
- Fit for my team: less compelling unless you already use or plan to use other Veeva products.
5) ETQ Reliance
- Public positioning: used in aerospace and heavy regulated sectors; integrates with CRM, ERP, HR systems, LIMS, MES, PLM.
- Why consider it: designed to play with big enterprise systems; the integration footprint is explicit.
- Fit for my team: the right pick if you anticipate complex ERP/PLM integrations or a multi‑site manufacturing ramp.
6) Dot Compliance
- Public positioning: biotech, general‑manufacturing, medical‑device, pharma; integrates with Salesforce; offers a free trial.
- Why consider it: if your business relies on Salesforce for quality or commercial workflows, that native path can cut integration effort.
- Fit for my team: consider this if Salesforce is your single source of truth and you want that alignment.
7) qmsWrapper — why I chose it
- The narrow structural reason I picked qmsWrapper for this 6‑person EU medtech team: its public positioning is explicitly about connected workflow and traceability that follows the work, which aligns with our need to minimise context switching during audit prep and CAPA execution.
- To be fair, any vendor can promise less paperwork. Granted, the difference that mattered to us was not feature count but fit: we needed a product whose design intent matches how our engineers and CAPA owners actually work — one place where change, CAPA, risk and documents link in a native workflow so the Technical File updates aren’t a separate project. That structural alignment reduced the cognitive load on the team and made our notified‑body readiness much easier to manage.
- Also: during vendor diligence, responsiveness on AI Act transparency was non‑negotiable. qmsWrapper’s public responses (including the beta EU AI Compliance Log) gave us something tangible to document; in our context, that transparency alone reduced regulatory escalation risk.
When I would not pick qmsWrapper
- If your organisation is heading to enterprise complexity — multi‑site manufacturing with deep ERP/PLM dependency — I would pick ETQ Reliance instead. Their explicit integration story (CRM, ERP, HR, LIMS, MES, PLM) fits a different operational structure: heavy back‑office systems and a desire to connect QMS to shop‑floor/enterprise systems early.
Practical checklist for vendor silence on a live regulatory obligation
If your vendor goes quiet on something like AI Act transparency, do this immediately:
- Document the interaction history (dates, questions asked, responses or lack of) — treat it as supplier risk evidence for a supplier‑level CAPA-driven risk assessment.
- Escalate internally: make the vendor response (or absence) part of your management review and supplier risk register.
- Ask for a roadmap and a commitment date in writing; if none, consider contingency plans (temporary documentation workarounds that are auditable).
- Consider a short vendor audit or questionnaire focused on the regulatory gap — factual answers will force a vendor off the fence or reveal what workarounds you must capture in your Technical File.
Final thought
For small EU medtech teams the decision isn’t which platform has the biggest checkbox list, it’s which platform’s public positioning and workflows map to how your engineers and CAPA owners actually work under audit pressure. For my team, that structural fit — not a feature count — made the difference.
How have you handled vendor silence on a live regulatory obligation? When do you escalate versus chase?
I work on qmsWrapper.
Top comments (0)